LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

Начало・Списък с акции・Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

Затворен

14.94 0.95

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

14.2

Максимум

15.15

Ключови измерители
By Trading Economics
Приходи	-23M -14M
Продажби	-22M 72M
EPS	-0.09
Марж на печалбата	-18.944
Служители	619
EBITDA	-23M -6.4M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+40.38% upside

Дивиденти
By Dow Jones
Следващи печалби	30.04.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-329M 2.5B
Предишно отваряне	13.99
Предишно затваряне	14.94

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

8.81 / 10.18 Подкрепа & съпротива

Adaptive Biotechnologies Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.03.2026 г., 18:13 ч. UTC

Придобивния, сливания и поглъщания

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9.03.2026 г., 17:20 ч. UTC

Значими събития в новините

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9.03.2026 г., 17:15 ч. UTC

Придобивния, сливания и поглъщания

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9.03.2026 г., 23:52 ч. UTC

Пазарно говорене

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

9.03.2026 г., 23:46 ч. UTC

Пазарно говорене

Значими събития в новините

Correction to Crude Prices Market Talk on March 9

9.03.2026 г., 23:42 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9.03.2026 г., 23:08 ч. UTC

Значими събития в новините

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9.03.2026 г., 23:07 ч. UTC

Значими събития в новините

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9.03.2026 г., 21:29 ч. UTC

Придобивния, сливания и поглъщания

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9.03.2026 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.03.2026 г., 20:47 ч. UTC

Значими събития в новините

The 24 Hours When Oil Markets Went Wild -- WSJ

9.03.2026 г., 20:33 ч. UTC

Значими събития в новините

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9.03.2026 г., 20:14 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9.03.2026 г., 19:33 ч. UTC

Значими събития в новините

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9.03.2026 г., 19:17 ч. UTC

Пазарно говорене

Значими събития в новините

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9.03.2026 г., 19:14 ч. UTC

Пазарно говорене

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9.03.2026 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Lower -- Market Talk

9.03.2026 г., 18:23 ч. UTC

Пазарно говорене

Значими събития в новините

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9.03.2026 г., 17:58 ч. UTC

Придобивния, сливания и поглъщания

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9.03.2026 г., 17:57 ч. UTC

Придобивния, сливания и поглъщания

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9.03.2026 г., 17:41 ч. UTC

Значими събития в новините

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9.03.2026 г., 17:41 ч. UTC

Пазарно говорене

Значими събития в новините

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9.03.2026 г., 17:08 ч. UTC

Пазарно говорене

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9.03.2026 г., 17:04 ч. UTC

Пазарно говорене

Значими събития в новините

Global Forex and Fixed Income Roundup: Market Talk

9.03.2026 г., 17:04 ч. UTC

Пазарно говорене

Значими събития в новините

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Adaptive Biotechnologies Corp Прогноза

Ценова цел

By TipRanks

40.38% нагоре

12-месечна прогноза

Среден 20.86 USD 40.38%

Висок 22 USD

Нисък 20 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Adaptive Biotechnologies Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

Купи

Задържане

Продай

Според 8 анализатори, дали борсови рейтинги на Adaptive Biotechnologies Corp през последните 3 месеца.

Техническа оценка

By Trading Central

8.81 / 10.18Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bullish.

There is one bullish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.